Pnc Financial Services Group, Inc. Terns Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $153 Billion
- Q2 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 779 shares of TERN stock, worth $6,317. This represents 0.0% of its overall portfolio holdings.
Number of Shares
779
Previous 483
61.28%
Holding current value
$6,317
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TERN
# of Institutions
133Shares Held
84.2MCall Options Held
173KPut Options Held
89.5K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$66.2 Million2.36% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$61.3 Million1.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.5MShares$60.8 Million0.99% of portfolio
-
Morgan Stanley New York, NY7.25MShares$58.8 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$55.9 Million5.45% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $305M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...